News

Shares of doughnut chain Krispy Kreme (NASDAQ:DNUT) fell 26.1% in the pre-market session after the company reported disappointing Q4 2024 results as it missed across all key metrics, including sales, operating profits, and earnings. Revenue fell 10.4% year on year, reflecting a decline in U.S. sales due to the Insomnia Cookies divestiture and the impact of a cybersecurity incident that cost an estimated $11 million in lost revenue.

Shares of healthcare services provider AdaptHealth Corp. (NASDAQ:AHCO) jumped 28% in the morning session after the company reported strong fourth-quarter 2024 results with revenue surpassing forecasts and driving EPS well above Wall Street estimates. While full-year revenue guidance came in slightly below expectations, full-year EBITDA guidance exceeded projections. Overall, this quarter had some key positives.

Richmond Fed president Tom Barkin said Tuesday that he wants to keep interest rates "modestly restrictive" until he gains more confidence inflation is returning to the central bank's 2% goal, warning about lessons learned from the 1970s.

Shares of casual restaurant chain Portillo’s (NASDAQ:PTLO) jumped 9.8% in the morning session after the company reported strong fourth-quarter 2024 results, significantly exceeding analysts' EPS expectations despite revenue coming in line with forecasts. EBITDA also outperformed Wall Street's estimates, showing that profitability was better than expected. Overall, we think this was a solid quarter with some key areas of upside.

Shares of medical products company UFP Technologies (NASDAQ:UFPT) jumped 9.9% in the afternoon session after the company delivered an encouraging quarter, surpassing analysts' expectations for revenue, EPS, and EBITDA. Sales surged 41.9% y/y, driven by strong performance in the MedTech segment, which grew 48.6%, while other markets saw a modest decline. Profitability improved as gross margins expanded to 29.2%, helping the company deliver the earnings beat.

Shares of infrastructure construction company Primoris (NYSE:PRIM) jumped 10.5% in the pre-market session after the company reported impressive fourth-quarter results that exceeded analysts' backlog, revenue, EPS, and EBITDA estimates. Revenue grew by 14.9% y/y, driven primarily by strong performance in the Energy and Utilities segments. Operating income saw a modest increase, as gross margins in the utilities segment improved significantly. Looking ahead, full-year EPS and EBITDA guidance excee

Shares of environmental solutions provider jumped 14.7% in the morning session after the company reported decent fourth-quarter results, surpassing analysts' expectations for revenue, EPS, and EBITDA. Revenue grew 3% y/y, driven by record-high bookings and a 46% increase in backlog, signaling strong demand across its industrial and environmental businesses. On top of that, the company's full-year revenue and EBITDA guidance came in ahead of forecasts, adding to the positive momentum. Zooming out

Shares of online insurance comparison site EverQuote (NASDAQ:EVER) jumped 31.5% in the pre-market session after the company reported a standout Q4 2024 result, with revenue and EBITDA significantly crushing Wall Street's estimates. Sales soared 165% compared to the previous year, fueled by a considerable rebound in the automotive insurance segment, which more than tripled. This sharp recovery highlights improving industry conditions and the company's ability to capitalize. On the profitability s

Tesla's stock tumbled 8% on Tuesday, pushing its market value below $1 trillion for the first time since November after data showed the electric car maker's sales slumped in Europe in January. The European Automobile Manufacturers Association reported that Tesla sales dropped 45% in Europe, compared with a 37% jump in overall sales of EVs in Europe. The sales decline underscores Tesla's challenges following a dip in global deliveries last year that has raised pressure on CEO Elon Musk to roll out lower-priced models as well as the autonomous cars that he says underpin Tesla's future.

Shares of Solventum jumped Tuesday and led S&P 500 gainers intraday after medical device maker Thermo Fisher Scientific said it would acquire the company’s purification and filtration business for $4.1 billion.